Corbus Pharmaceuticals Holdings, Inc. Quarterly Depreciation in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q3 2024.
  • Corbus Pharmaceuticals Holdings, Inc. Depreciation for the quarter ending September 30, 2024 was $200K, unchanged year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. Depreciation for the twelve months ending September 30, 2024 was $611K, a 20.3% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Depreciation for 2023 was $641K, a 16% decline from 2022.
  • Corbus Pharmaceuticals Holdings, Inc. annual Depreciation for 2022 was $763K, a 23.7% decline from 2021.
  • Corbus Pharmaceuticals Holdings, Inc. annual Depreciation for 2021 was $1M, a 11% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $611K $200K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $611K $200K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $611K $152K -$30.2K -16.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $641K $59.1K -$125K -67.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $766K $200K +$9.21K +4.83% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $757K $200K +$7.92K +4.12% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $749K $182K -$13.8K -7.08% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $763K $184K -$23.5K -11.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $786K $191K -$65.5K -25.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $852K $192K -$71.6K -27.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $924K $196K -$76.5K -28.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1M $208K -$74.4K -26.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $1.07M $256K +$54.2K +26.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.02M $264K -$56.5K -17.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $1.08M $272K -$47.3K -14.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.12M $282K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 $202K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $320K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $319K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q2 2017 $115K $33K +$13K +65.3% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $102K $31.5K +$13.7K +76.7% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $88K $29.8K +$12K +67.2% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-08
Q3 2016 $76K $20.5K +$5.76K +39.2% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $70.3K $19.9K +$13.8K +226% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $56.5K $17.8K +$12.5K +232% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $44K $17.8K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-08
Q3 2015 $14.7K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $6.12K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $5.37K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.